Newborn Screening Market 2019 Analysis Financial Performance, Strategies by (AB SCIEX, Bio-Rad Laboratories, Covidien, GE Life Sciences, Masimo Corporation, ZenTech) Industry to Rise 12.4% CAGR by 2026

Global Newborn Screening Market 2019-2026: Newborn screening programs test infants for disorders that are often not apparent at birth. Such disorders may be infectious, inherited, or caused by a medical problem in the mother. Early detection and treatment of some disorders can help prevent severe intellectual disability, health problems, growth problems, or even sudden infant death.

The global newborn screening market was valued at US$ 561.5 million in 2018, and is projected to reach at a CAGR of 12.4% over the forecast period (2018 – 2026).

Get a Quick Sample Brochure of this report at https://decisionmarketreports.com/request-sample?productID=983666

Furthermore, early disease diagnosis can reduce treatment cost. According to the Association of Public Health Laboratories 2012 report, the Medicaid cost of treating an infant with Severe Combined Immunodeficiency (SCID), which is fatal in the first two years of life without immune reconstitution, can reach US$ 2 million. However, if infants are diagnosed early, before developing life-threatening infections, from exposure to live childhood vaccines or common germs, they can be cured with a bone marrow transplant. The cost of the transplant is approximately US $100,000 when performed within the first 3.5 months of life.

Key features of the study:

• This report offers in-depth analysis of the global newborn screening market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the key players
• It profiles key players in the global newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Agilent Technologies, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., and ZenTech S.A.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for new born screening test market, research and consulting firms, new entrants, and financial analysts

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/983666/newborn-screening-market

Market Dynamics

Increasing number of newborn screenings, owing to rising awareness among parents and governments is expected to drive the newborn screening market growth. According to the Centers for Disease Control and Prevention (CDC) 2017, four million infants in the U.S. are routinely screened, using a few drops of blood from their heel, for certain endocrine, genetic, and metabolic disorders. The infants are also tested for hearing loss and Critical Congenital Heart Defects (CCHDs) prior to discharge from a hospital or birth center.

Furthermore, increasing incidence of hospital acquired diseases create an acute need for newborn screening. For instance, according to the Center for Disease Control and Prevention (CDC), in 2011, around one in every 25 infants was infected with at least one hospital acquired infections.

Government initiatives to support screening of newborns is also a major factor driving the newborn screening market. For instance, CDC is working to harness the latest advances in science and technology so that more disorders can be identified accurately and treated quickly. In 2005, CDC established the Newborn Screening Translation Research Initiative (NSTRI) with the CDC Foundation. NSTRI works with corporate, academic, and foundation partners to assure the quality of research methods during both pilot studies and routine screening.

However, lack of skilled professional, proper infrastructure and parent awareness in emerging regions are some of the major factors confining the newborn screening market. Moreover, the natural history for several diseases has not been well characterized and the effective follow-up and treatment may not be known. Excessive false-positive results of screening tests may produce additional costs to the healthcare system. However, improvements in newborn screening tests is expected to reduce number of false positives.

Detailed Segmentation:
• Global Newborn Screening Market, By Product:
o Assay Kits
o Hearing Screening Devices
o Mass Spectrometer
o Pulse Oximetry

• Global Newborn Screening Market, By Test:
• Blood Test
• Cardiac Test
• Hearing Test
• Urine Test

• Global Newborn Screening Market, By Application:
o Blood Spot Disease
o Critical Congenital Cardiac Disease
o Maple Syrup Urine Disease
o Hearing Disability
o Sickle Cell Disease
o Thyroid Disorder

• Company Profiles
o Agilent Technologies*
 Company Overview
 Product Portfolio
 Financial Performance
 Recent Highlights
 Strategies

o AB SCIEX
o Bio-Rad Laboratories
o Covidien PLC
o GE Life Sciences
o Masimo Corporation
o Natus Medical Inc.
o PerkinElmer Inc.
o ZenTech S.A.

For Better Insights help@decisionmarketreports.com

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Product
 Market Snippet, By Test
 Market Snippet, By Application
 Market Snippet, By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Regulatory Scenario
o Reimbursement Scenario
o PEST Analysis

4. Global Newborn Screening Market, By Product, 2018 - 2026, (US$ Million)
o Introduction
 Market Share Analysis, 2018 and 2026 (%)
 Y-o-Y Growth Analysis, 2017 – 2026
 Segment Trends
o Assay Kits
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Screening Devices
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Mass Spectrometer
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Pulse Oximetry
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)

5. Global Newborn Screening Market, By Application, 2018 - 2026, (US$ Million)
o Introduction
 Market Share Analysis, 2018 and 2026 (%)
 Y-o-Y Growth Analysis, 2017 – 2026
 Segment Trends
o Blood Spot Disease
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Critical Congenital Cardiac Disease
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Maple Syrup Urine Disease
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Disability
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Sickle Cell Disease
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Thyroid Disorder
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)

Request a In-depth Insights PDF Sample Brochure at https://decisionmarketreports.com/request-sample?productID=983666

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com

This release was published on openPR.